Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Scudla

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
Acta Universitatis Palackianae Olomucensis Facultatis Medicae|January 1, 1991
Clinical significance of correction of serum beta 2-microglobulin levels for serum creatinine in multiple myelomaV Scudla, V Vavrdová, M Budíková, et al.
Ceskoslovenska Patologie|September 8, 2006
[Bone marrow angiogenesis in patients with multiple myeloma as a marker of biological behaviour]V Tichá, M Tichý, V Scudla, et al.
Vnitrni Lekarstvi|November 1, 1990
[Cytogenetic study in multiple myeloma. II. Clinical significance of chromosomal changes]V Scudla, M Jarosová, M Kapustová, et al.
Vnitrni Lekarstvi|April 9, 2008
[The treatment of Waldenström macroglobulinemia and the therapy of diseases caused by monoclonal IgM gammaglobulin]Z Adam, V Scudla, M Krejcí, et al.
Vnitrni Lekarstvi|November 1, 1990
[Cytogenetic study in multiple myeloma. I. Chromosome findings in 56 patients]M Jarosová, V Scudla, K Indrák, et al.
Ceskoslovenska Patologie|August 1, 1986
[Primary hemangioendothelioma of the bone marrow]J Dusek, M Mrůzek, K Indrák, et al.
Acta Universitatis Palackianae Olomucensis Facultatis Medicae|January 1, 1991
Malignant lymphoma involving the heartI Krc, J Macák, Y Hrcková, et al.
Vnitrni Lekarstvi|September 1, 1995
[Serum interleukin-6 in multiple myeloma: I. Relation to selected laboratory indicators of disease]V Scudla, J Bacovský, M Budíková, et al.
Vnitrni Lekarstvi|September 1, 1995
[Serum interleukin-6 in multiple myeloma. II. Relation to activity and stage of disease]V Scudla, J Bacovský, M Budíková, et al.
Neoplasma|August 2, 2005
Scintigraphy using (99m)Tc-MIBI (sestamibi), a sensitive parameter of activity of multiple myelomaJ Bacovsky, V Scudla, M Myslivecek, et al.
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Acta Universitatis Palackianae Olomucensis Facultatis Medicae|January 1, 1991
Clinical significance of correction of serum beta 2-microglobulin levels for serum creatinine in multiple myelomaV Scudla, V Vavrdová, M Budíková, et al.
Ceskoslovenska Patologie|September 8, 2006
[Bone marrow angiogenesis in patients with multiple myeloma as a marker of biological behaviour]V Tichá, M Tichý, V Scudla, et al.
Vnitrni Lekarstvi|November 1, 1990
[Cytogenetic study in multiple myeloma. II. Clinical significance of chromosomal changes]V Scudla, M Jarosová, M Kapustová, et al.
Vnitrni Lekarstvi|April 9, 2008
[The treatment of Waldenström macroglobulinemia and the therapy of diseases caused by monoclonal IgM gammaglobulin]Z Adam, V Scudla, M Krejcí, et al.
Vnitrni Lekarstvi|November 1, 1990
[Cytogenetic study in multiple myeloma. I. Chromosome findings in 56 patients]M Jarosová, V Scudla, K Indrák, et al.
Ceskoslovenska Patologie|August 1, 1986
[Primary hemangioendothelioma of the bone marrow]J Dusek, M Mrůzek, K Indrák, et al.
Acta Universitatis Palackianae Olomucensis Facultatis Medicae|January 1, 1991
Malignant lymphoma involving the heartI Krc, J Macák, Y Hrcková, et al.
Vnitrni Lekarstvi|September 1, 1995
[Serum interleukin-6 in multiple myeloma: I. Relation to selected laboratory indicators of disease]V Scudla, J Bacovský, M Budíková, et al.
Vnitrni Lekarstvi|September 1, 1995
[Serum interleukin-6 in multiple myeloma. II. Relation to activity and stage of disease]V Scudla, J Bacovský, M Budíková, et al.
Neoplasma|August 2, 2005
Scintigraphy using (99m)Tc-MIBI (sestamibi), a sensitive parameter of activity of multiple myelomaJ Bacovsky, V Scudla, M Myslivecek, et al.
Pageof 8